Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vista Pharmaceuticals

BSE: 524711|ISIN: INE427C01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 17, 15:21
36.80
1.55 (4.4%)
VOLUME 16,243
Vista Pharmaceuticals is not listed on NSE
Announcements on Vista Pharma

12th-Jul-2018 11:35Source: BSE

Vista Pharmaceuticals- Statement Of Investor Complaints For The Quarter Ended June 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complai...

10th-Jul-2018 08:14Source: BSE

Vista Pharmaceuticals- Announcement under Regulation 30 (LODR)-Investor Presentation

PRESENTATION OF VISTA PHARMACEUTICALS LIMITED

29th-Jun-2018 17:00Source: BSE

Vista Pharmaceuticals- Board Meeting-Outcome of Board Meeting

With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at the meeting held on Friday, 29th June, 2018 at 04:00 PM at the Corporate office of the Company,...

27th-Jun-2018 11:00Source: BSE

Vista Pharmaceuticals- Intimation Of Board Meeting To Be Held On 29.06.2018

With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Friday, 29.06.2018 at 04.00 P.M at the Corporate office of ...

31st-May-2018 10:01Source: BSE

Vista Pharmaceuticals- General Announcement For Appointment Of Key Personnel (Technical)

Mr. Satyanarayana Sinha, is joining our organization as Vice President (Technical) from 1st June 2018.
He has 30 plus years of experience with multinational organizations. He has experience in the...

30th-May-2018 18:05Source: BSE

Vista Pharmaceuticals- Board Meeting-Outcome of Board Meeting

With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 30th May, 2018 at 04:30 PM, at the corporate office of the Compa...

29th-May-2018 10:35Source: BSE

Vista Pharmaceuticals- Announcement-ACQUISITION OF NEW ANDA

The company signed a Non-Disclosure Agreement (NDA) with a company to acquire a complex ANDA for UROCARE. The US market size for this BRAND is USD 1.3 billion (Rs8,840 Crores) as per the latest IMS da...

28th-May-2018 21:16Source: BSE

Vista Pharmaceuticals- General Announcement

The company facility was inspected by USFDA during February 1st to 9th, 2018 and issued 483 with 10 observations. The company already submitted partial response on March 12th and is in the process of ...

22nd-May-2018 13:50Source: BSE

Vista Pharmaceuticals- Board Meeting-Closure of Trading Window

Notice is hereby given that in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI (Prohibition of insider Trading) Regulations, 201...

22nd-May-2018 13:44Source: BSE

Vista Pharmaceuticals- Intimation Of Board Meeting To Be Held On 30.05.2018.

With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Wednesday, 30.05.2018 at 04.30 P.M at the Corporate office ...

1 2 3 4 5 Next >>
Quick Links for Vista Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.